Current Affairs - Economy - Discussion

In March 2025, India’s pharmaceutical exports experienced a remarkable YoY surge of 31.21%, reaching $3.68 billion compared to $2.80 billion in March 2024. This made March the strongest-performing month of FY25 in terms of export growth. The impressive increase was driven by a shortage of generic prescription drugs in the US, strategic diversification into new markets, and urgency to ship ahead of a proposed US tariff hike, which was later paused. Despite global economic and logistical challenges, this surge contributed significantly to India surpassing its annual pharmaceutical export target.